BD (NYSE: BDX) announced it received U.S. Food and Drug Administration 510(k) clearance and European Union CE marking for its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE